MoneyWorks4Me

Biocon to consider and approve unaudited quarterly Q3 results

08 Jan 2013 Evaluate
Biocon has informed that a meeting of the Board of directors of the company will be held on January 24, 2013, to consider and approve the unaudited financial results of the company for the quarter ended December 31, 2012.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..